Ana Vitória Pupo Silvestrini

Ana Vitória Pupo Silvestrini

Auto-generated profile, based on publicly available information

Ana Vitória Pupo Silvestrini

School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
LBLivia Neves Borgheti-Cardoso
Livia Neves Borgheti-Cardoso
JVJuliana S Rosa Viegas
Juliana S Rosa Viegas
ASAna Vitoria Pupo Silvestrini
Ana Vitoria Pupo Silvestrini
ACAngelo Luis Caron
Angelo Luis Caron
FPFabiola Garcia Praça
Fabiola Garcia Praça
MBMaria Vitoria Bentley
Maria Vitoria Bentley

18 September 2020 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
ASAna Vitoria Pupo Silvestrini
Ana Vitoria Pupo Silvestrini
ACAngelo Luis Caron
Angelo Luis Caron
JVJuliana S Rosa Viegas
Juliana S Rosa Viegas
FPFabíola Garcia Praça
Fabíola Garcia Praça
MBMaria Vitoria Bentley
Maria Vitoria Bentley
Lyotropic liquid crystals (LLCs) are organized mesophases with intermediate properties between liquids and solids. The LLC and its liquid crystalline nanoparticles (LCNPs) have attracted great inte...

14 February 2020 in Drug Delivery and Translational Research
Verified
Journal Article
Closed access
PDF file
JVJuliana S Rosa Viegas
Juliana S Rosa Viegas
FPFabiola Garcia Praça
Fabiola Garcia Praça
ACAngelo Luis Caron
Angelo Luis Caron
ISIsabella Suzuki
Isabella Suzuki
ASAna Vitoria Pupo Silvestrini
Ana Vitoria Pupo Silvestrini
MBMaria Vitoria Bentley
Maria Vitoria Bentley

1 December 2018 in Toxicon
Verified
Journal Article
Closed access
SMSilvana Pinotti Muller
Silvana Pinotti Muller
VSViviane Silva
Viviane Silva
ASAna Vitória Pupo Silvestrini
Ana Vitória Pupo Silvestrini
LMLuana Henrique de Macedo
Luana Henrique de Macedo
GCGuilherme Ferreira Caetano
Guilherme Ferreira Caetano
MMMaurício V Mazzi
Maurício V Mazzi

1 May 2018 in Toxicon
Verified
Journal Article
Closed access
DCDaniel Batista da Cunha
Daniel Batista da Cunha
ASAna Vitória Pupo Silvestrini
Ana Vitória Pupo Silvestrini
ASAna Carolina Gomes da Silva
Ana Carolina Gomes da Silva
DEDeborah Maria de Paula Estevam
Deborah Maria de Paula Estevam
FPFlávia Lino Pollettini
Flávia Lino Pollettini
MMMaurício Ventura Mazzi
Maurício Ventura Mazzi

14 January 2019 in Toxins
Verified
Journal Article
Open access
PDF file
ASAna Vitória Pupo Silvestrini
Ana Vitória Pupo Silvestrini
LMLuana Henrique de Macedo
Luana Henrique de Macedo
TAThiago Andrade
Thiago Andrade
MMMaíra Felonato Mendes
Maíra Felonato Mendes
APAcácio Antônio Pigoso
Acácio Antônio Pigoso
MMMaurício V Mazzi
Maurício V Mazzi
Crotamine is a single-chain polypeptide with cell-penetrating properties, which is considered a promising molecule for clinical use. Nevertheless, its biosafety data are still scarce. Herein, we assessed the in vivo proinflammatory properties of crotamine, including its local effect and systemic serum parameters. Sixty male Wistar rats were intradermically injected with 200, 400 and 800 µg crotamine and analyzed after 1, 3 and 7 days. Local effect of crotamine was assessed by determination of MPO and NAG activities, NO levels and angiogenesis. Systemic inflammatory response was assessed by determination of IL-10, TNF-α, CRP, NO, TBARS and SH groups. Crotamine induced macrophages and neutrophils chemotaxis as evidenced by the upregulation of both NAG (0.5–0.6 OD/mg) and MPO (0.1–0.2 OD/mg) activities, on the first and third day of analysis, respectively. High levels of NO were observed for all concentrations and time-points. Moreover, 800 μg crotamine resulted in serum NO (64.7 μM) and local tissue NO (58.5 μM) levels higher or equivalent to those recorded for their respective histamine controls (55.7 μM and 59.0 μM). Crotamine also induced a significant angiogenic response compared to histamine. Systemically, crotamine induced a progressive increase in serum CRP levels up to the third day of analysis (22.4–45.8 mg/mL), which was significantly greater than control values. Crotamine (400 μg) also caused an increase in serum TNF-α, in the first day of analysis (1095.4 pg/mL), however a significant increase in IL-10 (122.2 pg/mL) was also recorded for the same time-point, suggesting the induction of an anti-inflammatory effect. Finally, crotamine changed the systemic redox state by inducing gradual increase in serum levels of TBARS (1.0–1.8 μM/mL) and decrease in SH levels (124.7–19.5 μM/mL) throughout the experimental period of analysis. In summary, rats intradermally injected with crotamine presented local and systemic acute inflammatory responses similarly to histamine, which limits crotamine therapeutic use on its original form.